Prof. Ahmed El-Yazbi’s AIU faculty profile lists eight historical grants, with periods spanning 2014–2023: four as principal applicant and four as co-applicant. This is the Executive Director’s funding track record, not a count of active RDI awards. Project wording is shortened below.
| Period | Project focus | Funding programme | Role |
| 2020–2023 | Vascular dysfunction, thrombo-/adipose inflammation and DOACs | Medical Practice Plan | Principal |
| 2019–2022 | Gender differences in type 1 cardiorenal syndrome and metabolic impairment | Medical Practice Plan | Co-applicant |
| 2018–2020 | Cardiac autonomic dysfunction, adipose inflammation and phosphate supplementation | President’s Collaborative Research Stimulus | Principal |
| 2018–2019 | Metabolic stress, neuroinflammation, oral antidiabetic drugs and autophagy | Conseil National de la Receherche Scientifique | Principal |
| 2017–2020 | High-calorie intake, vascular dysfunction and oral antihyperglycaemic drugs | Medical Practice Plan | Principal |
| 2014–2016 | Hyperlipidaemia and the posaconazole–vincristine interaction | Science and Technology Development Fund — Young Investigator Grants | Co-applicant |
| 2014–2016 | Establishing a cell-culture laboratory at Alexandria University’s Medical Campus | Alexandria University Research Fund | Co-applicant |
| 2014–2016 | Heme oxygenase and cardiovascular effects of cyclosporine/NSAIDs | Alexandria University Research Fund | Co-applicant |
Research Inquiries
For inquiries about collaboration and the facilities described here, use the university’s published contact channels. The Executive Director’s university profile provides the linked leadership reference for RDI.